Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Pytel, Dariusz
One or more keywords matched the following items that are connected to Pytel, Dariusz
Item TypeName
Concept Protein-Tyrosine Kinases
Concept Protein Kinase Inhibitors
Concept Ribosomal Protein S6 Kinases
Concept eIF-2 Kinase
Concept Diacylglycerol Kinase
Concept Extracellular Signal-Regulated MAP Kinases
Concept Phosphatidylinositol 3-Kinases
Academic Article [Tyrosine kinases. New target of anticancer therapy].
Academic Article Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
Academic Article Comparative study of DNA damage, cell cycle and apoptosis in human K562 and CCRF-CEM leukemia cells: role of BCR/ABL in therapeutic resistance.
Academic Article Imatinib (STI571) inhibits DNA repair in human leukemia oncogenic tyrosine kinase-expressing cells.
Academic Article [The role of oncogenic tyrosine kinases in the cellular response to anticancer therapy].
Academic Article Tyrosine kinase blockers: new hope for successful cancer therapy.
Academic Article BCR/ABL stimulates WRN to promote survival and genomic instability.
Academic Article PERK utilizes intrinsic lipid kinase activity to generate phosphatidic acid, mediate Akt activation, and promote adipocyte differentiation.
Academic Article miR-211 is a prosurvival microRNA that regulates chop expression in a PERK-dependent manner.
Academic Article The ? isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling.
Academic Article Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer's Disease.
Academic Article Enzymatic Characterization of ER Stress-Dependent Kinase, PERK, and Development of a High-Throughput Assay for Identification of PERK Inhibitors.
Academic Article [Small molecule inhibitors of PERK-dependent signaling pathway as a novel, therapeutic molecular strategy in Alzheimer's disease treatment].
Academic Article PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma.
Academic Article Inhibition of PERK-dependent pro-adaptive signaling pathway as a promising approach for cancer treatment.
Academic Article Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment.
Academic Article [Niskoczasteczkowe inhibitory szlaku adaptacyjnej odpowiedzi na stres zaleznego od kinazy PERK jako nowatorska strategia terapeutyczna w leczeniu choroby Alzheimera].
Academic Article Inhibition of the PERK-Dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer's Disease.
Academic Article Potential therapeutic application of PERK inhibitors
Academic Article Use of Small-molecule Inhibitory Compound of PERK-dependent Signaling Pathway as a Promising Target-based Therapy for Colorectal Cancer.
Academic Article The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment.
Academic Article The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases.
Concept TOR Serine-Threonine Kinases
Academic Article Carbon Monoxide Activates PERK-Regulated Autophagy to Induce Immunometabolic Reprogramming and Boost Antitumor T-cell Function.
Search Criteria
  • Phosphotransferases